Avanos Net Debt from 2010 to 2025

AVNS Stock

USD 15.56 0.07 0.45%

Avanos Medical Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt is likely to outpace its year average in 2025. Net Debt is the total debt of Avanos Medical minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2013-12-31

Previous Quarter

126.1 M

Current Value

113.2 M

Quarterly Volatility

199.7 M

Yuan Drop

Covid

Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43 M, Interest Expense of 16.1 M or Selling General Administrative of 286.2 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.26 or PTB Ratio of 1.45. Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.

Check out the analysis of Avanos Medical Correlation against competitors.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Latest Avanos Medical's Net Debt Growth Pattern

Below is the plot of the Net Debt of Avanos Medical over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Avanos Medical's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avanos Medical's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Avanos Net Debt Regression Statistics

	Arithmetic Mean	158,422,083
	Geometric Mean	116,856,422
	Coefficient Of Variation	117.07
	Mean Deviation	141,076,458
	Median	121,400,000
	Standard Deviation	185,464,541
	Sample Variance	34397.1T
	Range	624M
	R-Value	(0.02)
	Mean Square Error	36842.3T
	R-Squared	0.0003
	Significance	0.95
	Slope	(693,853)
	Total Sum of Squares	515956.4T

Avanos Net Debt History

	2025	148.1 M
	2024	109.3 M
	2023	121.4 M
	2022	152.3 M
	2021	69 M
	2020	137.3 M
	2019	120.1 M

Other Fundumenentals of Avanos Medical

Net Debt To E B I T D A

Avanos Medical Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.9	-0.01	-0.18	0.78	0.83	0.94	0.95	0.75	0.17	0.19	0.8	0.03	0.22	0.54	0.87	0.88	0.23	0.35	0.03	-0.07	0.08	0.05	0.1
Total Stockholder Equity	0.9		0.08	-0.06	0.5	0.64	0.81	0.91	0.42	0.05	-0.09	0.64	-0.16	-0.04	0.65	0.85	0.83	-0.12	0.01	-0.16	0.17	-0.18	-0.17	-0.13
Net Tangible Assets	-0.01	0.08		-0.55	-0.1	-0.47	0.03	-0.22	-0.09	0.15	-0.41	0.28	-0.68	-0.41	0.48	0.36	-0.33	-0.34	-0.3	-0.85	0.54	-0.7	-0.78	-0.15
Retained Earnings	-0.18	-0.06	-0.55		-0.27	0.06	-0.36	0.02	-0.4	-0.76	-0.49	-0.41	0.53	-0.48	-0.47	-0.53	-0.05	-0.33	-0.35	0.52	-0.41	0.49	0.52	0.19
Accounts Payable	0.78	0.5	-0.1	-0.27		0.83	0.79	0.67	0.9	0.2	0.49	0.82	0.35	0.49	0.17	0.6	0.64	0.6	0.54	0.3	-0.3	0.33	0.36	0.13
Long Term Debt	0.83	0.64	-0.47	0.06	0.83		0.79	0.84	0.78	0.06	0.44	0.67	0.49	0.46	0.1	0.51	0.84	0.56	0.53	0.56	-0.42	0.53	0.56	0.17
Net Receivables	0.94	0.81	0.03	-0.36	0.79	0.79		0.86	0.84	0.32	0.31	0.84	-0.03	0.33	0.54	0.89	0.82	0.31	0.52	0.0	0.08	-0.03	-0.02	-0.11
Good Will	0.95	0.91	-0.22	0.02	0.67	0.84	0.86		0.62	0.03	0.15	0.61	0.11	0.19	0.44	0.77	0.96	0.1	0.28	0.12	-0.13	0.13	0.12	0.09
Total Liab	0.75	0.42	-0.09	-0.4	0.9	0.78	0.84	0.62		0.42	0.55	0.81	0.18	0.55	0.26	0.64	0.59	0.66	0.81	0.24	-0.17	0.25	0.25	0.09
Deferred Long Term Liab	0.17	0.05	0.15	-0.76	0.2	0.06	0.32	0.03	0.42		0.57	0.31	-0.48	0.56	0.56	0.43	0.09	0.43	0.48	-0.22	0.47	-0.3	-0.29	-0.22
Short Long Term Debt	0.19	-0.09	-0.41	-0.49	0.49	0.44	0.31	0.15	0.55	0.57		0.18	0.3	1.0	-0.11	0.14	0.36	0.8	0.64	0.38	-0.26	0.35	0.37	0.13
Total Current Assets	0.8	0.64	0.28	-0.41	0.82	0.67	0.84	0.61	0.81	0.31	0.18		-0.02	0.18	0.48	0.77	0.5	0.44	0.42	-0.01	0.07	-0.01	0.03	-0.09
Treasury Stock	0.03	-0.16	-0.68	0.53	0.35	0.49	-0.03	0.11	0.18	-0.48	0.3	-0.02		0.29	-0.68	-0.39	0.17	0.47	0.17	0.87	-0.79	0.89	0.91	0.42
Short Term Debt	0.22	-0.04	-0.41	-0.48	0.49	0.46	0.33	0.19	0.55	0.56	1.0	0.18	0.29		-0.09	0.17	0.4	0.78	0.62	0.38	-0.27	0.35	0.37	0.14
Intangible Assets	0.54	0.65	0.48	-0.47	0.17	0.1	0.54	0.44	0.26	0.56	-0.11	0.48	-0.68	-0.09		0.8	0.36	-0.24	-0.03	-0.62	0.66	-0.61	-0.66	-0.25
Common Stock	0.87	0.85	0.36	-0.53	0.6	0.51	0.89	0.77	0.64	0.43	0.14	0.77	-0.39	0.17	0.8		0.71	0.05	0.26	-0.41	0.37	-0.39	-0.4	-0.18
Property Plant Equipment	0.88	0.83	-0.33	-0.05	0.64	0.84	0.82	0.96	0.59	0.09	0.36	0.5	0.17	0.4	0.36	0.71		0.19	0.31	0.18	-0.17	0.17	0.17	0.09
Current Deferred Revenue	0.23	-0.12	-0.34	-0.33	0.6	0.56	0.31	0.1	0.66	0.43	0.8	0.44	0.47	0.78	-0.24	0.05	0.19		0.72	0.61	-0.42	0.59	0.62	0.23
Net Debt	0.35	0.01	-0.3	-0.35	0.54	0.53	0.52	0.28	0.81	0.48	0.64	0.42	0.17	0.62	-0.03	0.26	0.31	0.72		0.36	-0.17	0.3	0.32	0.05
Long Term Debt Total	0.03	-0.16	-0.85	0.52	0.3	0.56	0.0	0.12	0.24	-0.22	0.38	-0.01	0.87	0.38	-0.62	-0.41	0.18	0.61	0.36		-0.71	0.91	0.98	0.29
Capital Surpluse	-0.07	0.17	0.54	-0.41	-0.3	-0.42	0.08	-0.13	-0.17	0.47	-0.26	0.07	-0.79	-0.27	0.66	0.37	-0.17	-0.42	-0.17	-0.71		-0.88	-0.79	-0.7
Net Invested Capital	0.08	-0.18	-0.7	0.49	0.33	0.53	-0.03	0.13	0.25	-0.3	0.35	-0.01	0.89	0.35	-0.61	-0.39	0.17	0.59	0.3	0.91	-0.88		0.95	0.64
Net Working Capital	0.05	-0.17	-0.78	0.52	0.36	0.56	-0.02	0.12	0.25	-0.29	0.37	0.03	0.91	0.37	-0.66	-0.4	0.17	0.62	0.32	0.98	-0.79	0.95		0.39
Capital Stock	0.1	-0.13	-0.15	0.19	0.13	0.17	-0.11	0.09	0.09	-0.22	0.13	-0.09	0.42	0.14	-0.25	-0.18	0.09	0.23	0.05	0.29	-0.7	0.64	0.39

Click cells to compare fundamentals

About Avanos Medical Financial Statements

Avanos Medical shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Avanos Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Avanos Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	109.3 M	148.1 M
Net Debt To EBITDA	2.76	2.90

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Avanos Net Debt from 2010 to 2025

Latest Avanos Medical's Net Debt Growth Pattern

Avanos Net Debt Regression Statistics

Avanos Net Debt History

Other Fundumenentals of Avanos Medical

Avanos Medical Net Debt component correlations

About Avanos Medical Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Avanos Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY